I am a decision scientist (Ph.D). who uses insights on patient comprehension and motivation to arrive at their implications to adherence and outcomes. Some background: did my post-doc with Nobel Laureate Daniel Kahneman at Princeton University, 2005- 2009; taught consumer behavior at Wharton, and am now the founding director of the Center for Medical Decision Making at the Ono Academic College. My research deals with patient ocmprehension and motivation, and can be summarized under medical decision making, also involving physicians. I publish in peer-reviewed journals (Psychological Science, Health Psychology and more) and books (Oxford University, MIT Press). I have been very fortunate to combine my theoretical knowledge with my passion for change, and have been putting my extensive knowledge of decision making to use in my role as co-founder and CEO of CureMyWay, a start-up company that promotes behavioral change towards better health. My commitment to bridging industry and decision science led me to creating and chairing the startup panel at the Medicine 2.0 conference, and leading the Pharma 2.0 series for NYC's Health 2.0. I bring my insights on consumer and prescriber behavior and barriers to my work with big pharma: Johnson & Johnson, Pfizer, Novartis, BMS, Edelman PR, Draftfcb, and other health and media companies. Psychology Today is where I write more freely on health consumer issues.
Attended Medicine 2.0'11 (Stanford University, USA)
Attended Medicine 2.0'12 (Boston, USA)
Attended Medicine 2.0'13 (London, UK)
Medicine 2.0'11 (Stanford University, USA)
Digital Health - from a Concept to a Company
1. Who are the right investors for you and how to get their attention? 2. Which partners you should team with and when? 3. What are the business models to take into account? 4. What's the value of your IP? 5. Is non dilute funding a real alternative for traditional investments? Digital health is a fast growing industry with hundreds of new companies, a wide community of investors an uncountable number of fascinating case studies an tens of questions. This session will instruct you on various ...
Medicine 2.0'12 (Boston, USA)
Effects of Symptom Presentation Order on Perceived Disease Risk
Objective: The ability to distinguish meaningful patterns from meaningless coincidences is a vital part of human cognition. However, the mind is often too quick to infer meaning from coincidences. People expect random processes to produce fewer and shorter repetitions of the same event than is actually the case – the so-called “gambler’s fallacy”). This research examines how the appearance of streaks in symptom checklists influences personal assessments of risk. Methods: We carri...
From Idea to Company - Start Up Pitch and Expert Panel
A two-hour panel where academics who have an idea (and sometimes already results and funding) present it to the audience, as well as to an esteemed panel of experts, representing various angles of the industry. The panelists then provide the companies with valuable feedback, which informs both the companies and the entrepreneurs in the audience about the process to create a company or to receive venture capital funding. Think "Dragons' Den" or "Shark Tank" for ehealth/mhealth! Pitches to b...
Medicine 2.0'13 (London, UK)
Start-up Panel: Industry Meets Academia
Scientists often have incredible ideas which, if put to commercial use, would make a difference. But how does one go about this? The start-up panel is a unique encounter between scientists who are also entrepreneurs, and industry experts from VCs (venture capital firms), pharma, and other potnetial interested parties. We invite anyone who has an idea and have started implementing it, in varying degrees of maturity, to present and receive invaluable feedback and exposure. Even merely at...
Medicine 2.0'14 Europe (Malaga, Spain)
Demographic and Health Related Data of Users of a Mobile Application to Support Drug Adherence Is Associated with Usage Duration and Intensity
Background: Drug adherence is a problem in the management of patients with chronic conditions. Numerous mobile applications try to support users in their regular and correct drug intake. Yet high attrition and digital divide is described in the usage of health-related apps. On developing software for patients it is therefore important to know whether users are likely to login a mobile application by themselves and who may need further assistance. Objective: To analyze demographic- and ...
Full Paper Publications
Interactive Journal of Medical Research
“A Phenomenal Person and Doctor”: Thank You Letters to Medical Care Providers
JMIR mHealth and uHealth
mHealth 2.0: Experiences, Possibilities, and Perspectives
Journal of Medical Internet Research
Promoting Business and Entrepreneurial Awareness in Health Care Professionals: Lessons From Venture Capital Panels at Medicine 2.0 Conferences
This user's work may be related to
Users who have said they are friend/colleague of Talya Miron-shatz
Users who said they have met Talya Miron-shatz
Users who said they want to meet Talya Miron-shatz
Medicine 2.0® is happy to support and promote other conferences and workshops in this area. Contact us to produce, disseminate and promote your conference or workshop under this label and in this event series. In addition, we are always looking for hosts of future World Congresses. Medicine 2.0® is a registered trademark of JMIR Publications Inc., the leading academic ehealth publisher.
This work is licensed under a Creative Commons Attribution 3.0 License.